American Journal of Pharmacological Sciences
The aim of this special issue is to present articles to evaluate the beneficial effect of statins on diseases other than dyslipidemia. There is a big controversy in literature when evaluating the pleiotropic effect of statins and many of these studies are done in a small scale which further complicates acquiring correct and clear conclusions. So further studies are helping the scientific community to gain deep understanding of the pleiotropic effect of statins and either opens a new gate for additional indications for statins or close the door for further research in this respect.
About the issue
The scope of topics covered in the this issue include:
Submission Deadline: February 01, 2015Notification of Acceptance: March 01, 2015Final Version Due: April 01, 2015Special Issue Publishing Date: May, 2015
Chief Guest Editor
Ehab MikhaelBaghdad University – College of PharmacyEmail: firstname.lastname@example.org
Guest EditorSaad Abdul-Rehman HussainBaghdad University – College of PharmacyEmail: email@example.com
Submit your article now
Manuscripts should be submitted as an attached file to an e-mail directed to the Chief Guest Editor, Ehab Mikhael at the address: <firstname.lastname@example.org>
or through the journal’s Paper Submission System.
Varied researches are focused in producing safe, effective and inexpensive medicines for many of the neglected infectious diseases (NEGD), currently affecting more than one billion individuals, mostly poor people. The WHO list of NEGD comprises 17 conditions for which there are scarce effective drugs and treatments available.
Much research activity has been published for NEGD treatments. Varied groups claim that their work could lead to new therapies for NEGD, but few in fact do. Whilst scientists, research centers, universities and funders keep focusing on papers and patents, patients are not yet being reached by the published results.
It is well known, however, that the discovery of a new drug is a multi-stage complex process, lasting for several years. Discovering drugs to NEGD is still a challenging task for researchers, due to the intricate pathways involved in host-parasite interactions. Also, political, economic and regulatory processes make the process of discovery or repositioning even more long lasting, increasing the cost of drug discovery considerably. In this context, drug repositioning becomes a feasible opportunity, representing nearly 30% of the US Food and Drug Administration (FDA) approved drugs recently.
Chemoinformatics deals with discovering drugs based in modern drug discovery techniques which in turn provides solutions to complex issues in drug discovery. Molecular methods are also being even more explored in drug discovery, given that the knowledge of the genetic background may give more direction of conclusion for key aspects of drug discovery or repositioning. However, as exposed, such results are not reaching affected patients.
This issue, therefore, aims to explore translational research regarding molecular and computational investigations in drug discovery and repositioning for neglected diseases, opening doors not only for discussions on the topic, but for opportunities to speed up the application of basic research in clinical practice.
Submission Deadline: January 10, 2015Notification of Acceptance: February 20, 2015Final Version Due: March 30, 2015Special Issue Publishing Date: April 30, 2015
Marcus V. Dias-SouzaBiological Sciences Institute, Federal University of Minas Gerais, Brazil.Email: email@example.com
Guest EditorPedro MarçalBiological Sciences Institute, Federal University of Juiz de Fora, Brazil.Email: firstname.lastname@example.org
Flávio FigueiredoHealth and Human Development Faculty, Santo Agostinho Institute, BrazilEmail: email@example.com
Swiany LimaBiological Sciences Institute, Federal University of Minas Gerais, Brazil.Email: firstname.lastname@example.org
Manuscripts should be submitted as an attached file to an e-mail directed to the Chief Guest Editor, Marcus V. Dias-Souza at the address: <email@example.com>
Microbial diseases are responsible for heavy mortality in human beings. The problems in the farms are usually tackled by preventing disease outbreaks or by treating the actual disease with drugs or chemicals. Antibiotics used in both human as well as veterinary medicines have been tried experimentally to treat microbial infections. Decreased efficacy and resistance of pathogens to antibiotics has necessitated development of new alternatives. Microbial resistance to antibiotics has been a great problem for many years. Due to the in discriminating use of antimicrobial drugs, the microorganisms have developed resistance to many commercial antibiotics. Development of such newer disease causing pathogens and evolution of existing microorganisms has resulting severe consequences including mortality of patients. The expanding bacterial resistance to antibiotics has become a growing concern worldwide. Intensive care physicians consider antibiotic resistance bacterial a significant problem in the treatment of patients. Increasing bacterial resistance is prompting resurgence in research of the antimicrobial role of herbs against resistant strains. A vast number of natural products have been recognized as valuable resources of natural antimicrobial compounds. The special issue on “Infectious Diseases and Alternative Medicines” in “American Journal of Pharmacological Science” will publish high quality research and review articles which contribute new scientific findings in all areas of Pharmaceutical Science. The journal welcomes the researchers for the submission of their high quality research and review paper.
Submission Deadline: November 30, 2014Notification of Acceptance: December 30, 2014Final Version Due: January 15, 2014Special Issue Publishing Date: January 30, 2015
Dr. P. SaranrajDepartment of Microbiology, Annamalai University, Chidambaram, Tamil Nadu, India.Email: firstname.lastname@example.org
Guest EditorDr. Murugan ThiraviamDepartment of Medicine, College of Medicine and Health Sciences, Ambo University, Ambo, Ethiopia.Email: email@example.com
Dr. Jayachandran SubburajCAS in Marine Biology, Annamalai University, Parangipettai, Tamil Nadu, India.Email: firstname.lastname@example.org
Manuscripts should be submitted as an attached file to an e-mail directed to the Chief Guest Editor, Dr. P. Saranraj at the address: <email@example.com>
In the face of rising demands and skyrocketing costs, all the occupations and institutions in the field of health care are being challenged to develop more effective and economical interventions for the delivery of their services. Improvement in medicine use is very much dependent on the health systems within which care is delivered. The contributions of pharmacy practice has helped many countries in achieving better health outcomes, reducing the costs of treatment, building the patient trust on healthcare system, reduced side effects and risk of treatments, decreased morbidity and mortality, improved access to safe and timely treatments and improved quality of life resulting in achievements of millennium development goals.
This issue will contain state-of-the-art reviews and original research articles covering outstanding and most recent research from the eminent scientists working in the field of pharmacy practice. This issue not only highlights the major challenges and their solutions in designing optimizing patient care models but also in-depth mechanism relating to the strategies of overcoming the irrational drug use will be presented. It is envisaged that this issue will contain 5-10 outstanding manuscripts including original research and outstanding review articles from authors around the globe.
Submission Deadline: October 01, 2014Notification of Acceptance: October 31, 2014Final Version Due: November 15, 2014Special Issue Publishing Date: December 15, 2014
Madeeha MalikHamdard Institute of Pharmaceutical Sciences, Hamdard University, Islamabad, PakistanEmail: firstname.lastname@example.org
Guest EditorAzhar HussainHamdard Institute of Pharmaceutical Sciences, Hamdard University, Islamabad, PakistanEmail: email@example.com
M. ShafiqHamdard Institute of Pharmaceutical Sciences, Hamdard University, Islamabad, PakistanEmail: firstname.lastname@example.org
Manuscripts should be submitted as an attached file to an e-mail directed to the Chief Guest Editor, Madeeha Malik at the address: <email@example.com>
Drug delivery through skin is an attractive alternative to the conventional routes and offers completely non-invasive to minimally invasive drug delivery options for the better compliance of the patients. The beauty of skin is its impermeability which ensures survival on the dry land. Skin not only protects internal organs from injury but also restricts ingress of foreign entities, protects form harmful irradiations and most importantly water evaporation form the body. With all these unique characteristics, skin has been extensively studied to overcome its barrier properties reversibly in order to deliver therapeutic agents. Not only delivering drugs remained the major objective, but also accidental exposure of chemicals for the risk assessment has been extensively studied over the years.
This issue will contain state-of-the-art reviews and original research articles covering outstanding and most recent research from the eminent scientists working in the field of drug delivery through skin. This issue not only highlights the major challenges and their solutions in designing optimum formulations for skin delivery but also in-depth mechanism relating to the strategies of overcoming the barrier properties of the skin will be presented. It is envisaged that this issue will contain 5-10 outstanding manuscripts including original research and outstanding review articles form authors around the globe.
Submission Deadline: September 30, 2014Notification of Acceptance: October 31, 2014Final Version Due: November 15, 2014Special Issue Publishing Date: December 15, 2014
Yasser ShahzadNorth-West UniversityEmail: firstname.lastname@example.org
Guest EditorMadeeha MalikHamdard UniversityEmail: email@example.com
Manuscripts should be submitted as an attached file to an e-mail directed to the Chief Guest Editor, Yasser Shahzad at the address: <firstname.lastname@example.org>
Mankind is dependent on the various gifts of nature especially on the plant kingdom, from the first day of their lives for the different facets of life, including the health care system as well. Since time immemorial, plants have been extensively used by the people for the treatment of myriad disease and disorders. The rational study on folklore medicine provides a valuable approach in the search for the development of new and effective therapeutic agents from the arsenal of natural products.Nowadays diabetes is one of the most vulnerable diseases worldwide, especially because of the lack of the appropriate drug that can control completely the pathological condition without producing any side effects. Most of the current therapeutic agents have some sort of adverse effects, so the scientists from different parts of the world are actively engaged in the search of biomolecules from herbals, which has less adverse effects but significant pharmacological action, at the same time, is cost effective. Antidiabetic agents from plant origin are often found to be less toxic or sometimes nontoxic in nature.
People of 21st century are very much busy and their life style is responsible for one of the deadly disease diabetes, also known as silent killer. Several countries established more and less successful national diabetes programmes to improve treatment of the disease. Diabetes is a disease for both developed and developing countries. Natural remedies for diabetes are considered significantly due to their less toxic effects and economical point of view. Naturally occurring compounds are of great interest to biologist because these compounds can be tailored following an appreciate choice of the legend, granting to these compounds a potential for multiple applications. Exercise (Yoga), food supplement and maintenance of life style play a major role for the management of diabetes and its complications.
Submission Deadline: September 17, 2013Notification of Acceptance: October, 2013Final Version Due: November, 2013Special Issue Publishing Date: December, 2013
Dr. Sagar NaskarBengal College of Pharmaceutical Sciences and ResearchEmail: Sagar_n2007@yahoo.co.in
Dr. Pallab Kanti HaldarDepartment of Pharmaceutical Technology, Jadavpur UniversityEmail: Pallab_haldar@rediffmail.com
Dr. Aminul IslamNatreon Inc. (an USA based research centre)Email: email@example.com
If you would like to submit an article to this special issue, please send your submissions via email directly to our guest editor, Sagar Naskar<Sagar_n2007@yahoo.co.in>.